JP2022527917A5 - - Google Patents
Info
- Publication number
- JP2022527917A5 JP2022527917A5 JP2021557657A JP2021557657A JP2022527917A5 JP 2022527917 A5 JP2022527917 A5 JP 2022527917A5 JP 2021557657 A JP2021557657 A JP 2021557657A JP 2021557657 A JP2021557657 A JP 2021557657A JP 2022527917 A5 JP2022527917 A5 JP 2022527917A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- aav
- sequence
- library
- heptamer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025044435A JP2025098107A (ja) | 2019-03-28 | 2025-03-19 | 導入遺伝子発現のための操作されたアデノ随伴(aav)ベクター |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962825703P | 2019-03-28 | 2019-03-28 | |
| US62/825,703 | 2019-03-28 | ||
| PCT/US2020/025720 WO2020198737A1 (en) | 2019-03-28 | 2020-03-30 | Engineered adeno-associated (aav) vectors for transgene expression |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025044435A Division JP2025098107A (ja) | 2019-03-28 | 2025-03-19 | 導入遺伝子発現のための操作されたアデノ随伴(aav)ベクター |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022527917A JP2022527917A (ja) | 2022-06-07 |
| JP2022527917A5 true JP2022527917A5 (cg-RX-API-DMAC7.html) | 2023-04-06 |
| JP7659271B2 JP7659271B2 (ja) | 2025-04-09 |
Family
ID=72609527
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021557657A Active JP7659271B2 (ja) | 2019-03-28 | 2020-03-30 | 導入遺伝子発現のための操作されたアデノ随伴(aav)ベクター |
| JP2025044435A Pending JP2025098107A (ja) | 2019-03-28 | 2025-03-19 | 導入遺伝子発現のための操作されたアデノ随伴(aav)ベクター |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025044435A Pending JP2025098107A (ja) | 2019-03-28 | 2025-03-19 | 導入遺伝子発現のための操作されたアデノ随伴(aav)ベクター |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20220195458A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3947422A4 (cg-RX-API-DMAC7.html) |
| JP (2) | JP7659271B2 (cg-RX-API-DMAC7.html) |
| KR (2) | KR20260036045A (cg-RX-API-DMAC7.html) |
| CN (1) | CN113874387B (cg-RX-API-DMAC7.html) |
| AU (2) | AU2020248116B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112021019436A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3135292A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL286725A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2021011701A (cg-RX-API-DMAC7.html) |
| SG (1) | SG11202110165XA (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020198737A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019200016A1 (en) | 2018-04-10 | 2019-10-17 | President And Fellows Of Harvard College | Aav vectors encoding clarin-1 or gjb2 and uses thereof |
| CA3087238A1 (en) | 2018-05-24 | 2019-11-28 | Celanese EVA Performance Polymers Corporation | Implantable device for sustained release of a macromolecular drug compound |
| EP3803866A4 (en) | 2018-05-24 | 2022-03-16 | Nureva Inc. | METHOD, APPARATUS, AND COMPUTER READABLE MATERIALS FOR MANAGING SEMI-CONSTANT (PERSISTENT) SOUND SOURCES IN MICROPHONE CATCH/HOME AREAS |
| CN111989068B (zh) | 2018-05-24 | 2024-10-25 | 塞拉尼斯伊娃高性能聚合物公司 | 用于持续释放大分子药物化合物的可植入器件 |
| US11149256B2 (en) | 2018-09-26 | 2021-10-19 | California Institute Of Technology | Adeno-associated virus compositions for targeted gene therapy |
| EP3959324B1 (en) | 2019-04-26 | 2025-09-17 | President and Fellows of Harvard College | Aav vectors encoding mini-pcdh15 and uses thereof |
| AU2020366531A1 (en) * | 2019-10-18 | 2022-05-26 | Research Institute At Nationwide Children's Hospital | Gene therapy targeting cochlear cells |
| FI4103214T3 (fi) | 2020-02-13 | 2026-07-03 | Tenaya Therapeutics Inc | Geeniterapian vektorit sydänsairauden hoitoon |
| US12129287B2 (en) | 2020-09-14 | 2024-10-29 | President And Fellows Of Harvard College | Recombinant adeno associated virus encoding clarin-1 and uses thereof |
| US20240075167A1 (en) * | 2021-02-03 | 2024-03-07 | The Board Of Trustees Of The Leland Stanford Junior University | Method of gene delivery to retinal astrocytes |
| EP4329734A4 (en) | 2021-04-26 | 2025-04-02 | Celanese EVA Performance Polymers LLC | Implantable device for the delayed release of a macromolecular drug compound |
| TW202317768A (zh) | 2021-07-08 | 2023-05-01 | 美商特納亞治療股份有限公司 | 用於基因療法的優化表現卡匣 |
| KR20240095539A (ko) | 2021-10-08 | 2024-06-25 | 디노 테라퓨틱스, 인코포레이티드 | 캡시드 변이체 및 이의 사용 방법 |
| CN114606264B (zh) * | 2022-03-22 | 2025-08-26 | 三峡大学 | 一种用于神经系统药物递送的aav病毒载体 |
| WO2024054864A1 (en) | 2022-09-06 | 2024-03-14 | Tenaya Therapeutics, Inc. | Cardioprotective heart disease therapies |
| JP2026509271A (ja) | 2023-03-10 | 2026-03-17 | ダイノ セラピューティクス,インコーポレーテッド | カプシドポリペプチドおよびその使用方法 |
| EP4695396A1 (en) | 2023-04-10 | 2026-02-18 | Tenaya Therapeutics, Inc. | Guide rnas, vectors, and virions for targeting mutations in the pln gene |
| WO2024215655A1 (en) | 2023-04-10 | 2024-10-17 | Tenaya Therapeutics, Inc. | Cardioprotective bag3 therapies |
| WO2024220545A2 (en) * | 2023-04-17 | 2024-10-24 | The General Hospital Corporation | Aav capsids for on-target delivery to spinal cord |
| EP4698555A1 (en) * | 2023-04-18 | 2026-02-25 | uniQure biopharma B.V. | Novel neurotropic adeno-associated virus capsids with detargeting of peripheral organs |
| KR20260082361A (ko) | 2023-08-31 | 2026-06-04 | 디노 테라퓨틱스, 인코포레이티드 | 캡시드 폴리펩타이드 및 이의 사용 방법 |
| TW202545971A (zh) | 2024-02-08 | 2025-12-01 | 美商戴諾治療公司 | 殼體多肽及其使用方法 |
| WO2026064442A2 (en) | 2024-09-18 | 2026-03-26 | Dyno Therapeutics, Inc. | Capsid polypeptides and methods of use thereof |
| WO2026122963A1 (en) | 2024-12-06 | 2026-06-11 | Dyno Therapeutics, Inc. | Capsid polypeptides and methods of use thereof |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7504490B1 (en) * | 1998-10-16 | 2009-03-17 | Oscient Pharmaceuticals Corporation | Nucleic acid and amino acid sequences relating to Apergillus fumigatus for diagnostics and therapeutics |
| ES2547381T3 (es) * | 2004-04-09 | 2015-10-05 | Monsanto Technology, Llc | Composiciones y procedimientos de control de infestaciones de insectos en plantas |
| US7588772B2 (en) * | 2006-03-30 | 2009-09-15 | Board Of Trustees Of The Leland Stamford Junior University | AAV capsid library and AAV capsid proteins |
| EP2058401A1 (en) * | 2007-10-05 | 2009-05-13 | Genethon | Widespread gene delivery to motor neurons using peripheral injection of AAV vectors |
| NZ716102A (en) * | 2013-07-22 | 2021-12-24 | The Children’S Hospital Of Philadelphia | Variant aav and compositions, methods and uses for gene transfer to cells, organs and tissues |
| EP3564379A1 (en) * | 2013-09-13 | 2019-11-06 | California Institute of Technology | Selective recovery |
| US10307492B2 (en) * | 2014-03-11 | 2019-06-04 | Wayne State University | Modified MGLUR6 promoter and methods of use |
| AU2016366549B2 (en) * | 2015-12-11 | 2022-11-10 | California Institute Of Technology | Targeting peptides for directing adeno-associated viruses (AAVs) |
| GB2545763A (en) * | 2015-12-23 | 2017-06-28 | Adverum Biotechnologies Inc | Mutant viral capsid libraries and related systems and methods |
| CA3011939A1 (en) * | 2016-02-02 | 2017-08-10 | University Of Massachusetts | Method to enhance the efficiency of systemic aav gene delivery to the central nervous system |
| JP6994018B2 (ja) * | 2016-07-26 | 2022-01-14 | バイオマリン ファーマシューティカル インコーポレイテッド | 新規アデノ随伴ウイルスキャプシドタンパク質 |
| EP4219806A3 (en) | 2017-04-11 | 2023-09-27 | Ruprecht-Karls-Universität Heidelberg | Adeno-associated virus library |
| US11512327B2 (en) * | 2017-08-03 | 2022-11-29 | Voyager Therapeutics, Inc. | Compositions and methods for delivery of AAV |
| MX2020001997A (es) * | 2017-08-28 | 2020-07-20 | Univ California | Variantes de capside de virus adenoasociado y metodos de uso de estas. |
| CA3092107A1 (en) * | 2018-02-28 | 2019-09-06 | The University Of North Carolina At Chapel Hill | Methods and compositions for antibody-evading virus vectors |
| CN109207520B (zh) * | 2018-09-25 | 2022-05-10 | 北京锦篮基因科技有限公司 | Leber遗传性视神经病变的基因药物 |
-
2020
- 2020-03-30 JP JP2021557657A patent/JP7659271B2/ja active Active
- 2020-03-30 US US17/442,894 patent/US20220195458A1/en active Pending
- 2020-03-30 WO PCT/US2020/025720 patent/WO2020198737A1/en not_active Ceased
- 2020-03-30 KR KR1020267006391A patent/KR20260036045A/ko active Pending
- 2020-03-30 BR BR112021019436A patent/BR112021019436A2/pt unknown
- 2020-03-30 EP EP20779113.8A patent/EP3947422A4/en active Pending
- 2020-03-30 KR KR1020217034532A patent/KR102934700B1/ko active Active
- 2020-03-30 AU AU2020248116A patent/AU2020248116B2/en active Active
- 2020-03-30 CN CN202080038934.8A patent/CN113874387B/zh active Active
- 2020-03-30 CA CA3135292A patent/CA3135292A1/en active Pending
- 2020-03-30 SG SG11202110165XA patent/SG11202110165XA/en unknown
- 2020-03-30 MX MX2021011701A patent/MX2021011701A/es unknown
-
2021
- 2021-09-26 IL IL286725A patent/IL286725A/en unknown
-
2025
- 2025-03-19 JP JP2025044435A patent/JP2025098107A/ja active Pending
-
2026
- 2026-02-26 AU AU2026201434A patent/AU2026201434A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN113874387B (zh) | 用于转基因表达的工程化腺相关病毒(aav)载体 | |
| CN105408352B (zh) | 通过双重aav载体有效递送大基因 | |
| JP7182873B2 (ja) | 多重ベクターシステム及びその使用 | |
| CN112703016B (zh) | 肌球蛋白15启动子及其用途 | |
| CN100422320C (zh) | 编码抗肌萎缩蛋白小基因的dna序列及其使用方法 | |
| CN103764831B (zh) | 不含衣壳的aav载体、组合物以及制备载体和基因递送的方法 | |
| CN114072179B (zh) | 肌球蛋白15启动子及其用途 | |
| TW202100748A (zh) | 恢復肌縮蛋白功能之基於crispr/cas之基因組編輯組合物 | |
| JP2021530218A5 (cg-RX-API-DMAC7.html) | ||
| US12467066B2 (en) | Compositions and methods for treating retinal disorders | |
| CN113785063A (zh) | 用于治疗杜氏肌营养不良症的aav载体介导的大规模突变热点缺失 | |
| CN108699565A (zh) | 用于定向腺相关病毒(aav)的靶向肽 | |
| KR20250084964A (ko) | 구성적 유전자 발현을 위한 핵산 조절 요소 및 사용 방법 | |
| EP4602061A1 (en) | Atp7b gene therapy | |
| US20250026795A1 (en) | Functional aav capsids for intravitreal administration | |
| KR20230112672A (ko) | 신경변성 질환을 위한 유전자 요법 | |
| CN121311586A (zh) | 耳蜗內毛细胞特异性启动子及其应用 | |
| RU2021131423A (ru) | Сконструированные аденоассоциированные (aav) векторы для экспрессии трансгена | |
| KR20240052746A (ko) | Kcnv2 유전자 요법 | |
| WO2025090628A1 (en) | Compositions and methods comprising small nuclear rna (snrna) for treating genetic epilepsies | |
| WO2026033140A1 (en) | Variant aav capsid polypeptides targeting the eye | |
| WO2025212745A1 (en) | Engineered adeno-associated virus (aav) capsid protein and uses thereof | |
| EP4728080A1 (en) | A hybrid dual aav vector system with splice enhancer elements for expression of large genes | |
| CN116761812A (zh) | Neurod1和dlx2载体 |